Balanced news tone
News Sentiment
SGP sentiment intelligence
SpyGlass Pharma, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+17.6% over one week, +22.1% over four weeks, trend inactive, and near fair-value range.
Top Spyglass Pharma (SGP) Competitors 2026
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 20:05
- Source
- GlobeNewswire
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Spyglass Pharma (SGP) Earnings Date and Reports 2026 $SGP
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Feb 2026 04:54
- Source
- MarketBeat
Spyglass Pharma (SGP) Stock Price, News & Analysis $SGP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Feb 2026 17:53
- Source
- MarketBeat
Spyglass Pharma (SGP) Stock Forecast and Price Target 2026 $SGP
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 17 Feb 2026 17:48
- Source
- MarketBeat
SpyGlass Pharma Announces Closing of Initial Public
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- GlobeNewswire
SpyGlass Pharma closes $172.5 million IPO on NASDAQ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- Investing.com
SpyGlass Pharma, Inc (SGP) Stock Price Today & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Feb 2026 21:08
- Source
- Gotrade
SpyGlass Pharma - SGP - Stock Price & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 17:51
- Source
- The Motley Fool
Spyglass Pharma shares surge 50% in Nasdaq debut
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Investing.com
Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Bloomberg.com
SpyGlass Pharma Rings the Nasdaq Stock Market Opening Bell
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Nasdaq
Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Fierce Biotech
SpyGlass Pharma Announces Pricing of Initial Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- GlobeNewswire
SpyGlass Pharma Sees IPO Ahead For Its Ocular Pressure Treatment Candidates (Pending: SGP)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- Seeking Alpha